Senior U.S. government officials: U.S. President Trump will announce an agreement with nine pharmaceutical companies to lower drug prices. Pharmaceutical companies will receive U.S. tariff reductions as an exchange for participating in the drug price reduction agreement. Among the 17 leading pharmaceutical companies, 14 have already joined the Trump administration's 'Most Favored Nation' initiative.